Entac Medical, Inc.
Germantown, US · Founded 2011 · Delaware corporation · 4 known investors
Find your way into Entac Medical, Inc.
70 people in our graph share verified history with the Entac Medical, Inc. team — schools, employers, funds. One of them is your warm intro.
Josh Felserunlockedknows Buddy Lyons · together at Duke University - The Fuqua School of Business (overlapped)
×2knows the team · via Duke University - The Fuqua School of Business
×9knows the team · via Darla Moore School of Business at the University of South Carolina
Entac Medical develops wearable devices that apply predictive analytics and AI to biological acoustic signals to predict patient adverse events, aiming to improve patient outcomes and reduce hospital readmissions and cost of care. It serves the healthcare sector as a digital health company.
Founders & leadership
Entac Medical, Inc. was founded in 2011 by John W. Cromwell, MD and Buddy Lyons.
JW
John W. Cromwell, MDDr. Cromwell is a Member of the Issuer.
BL
Buddy LyonsinCEO/FounderLyons has founded or co-founded several medtech and healthcare ventures, including tauSpan Technologies, Excere Medical, Umbokleen and MalcolmAI, and previously served as chief financial officer of arGentis Pharmaceuticals. Earlier in his career he covered biotechnology as an equity analyst, serving as senior vice president at Stanford Group Company and vice president at Morgan Keegan.
BL
Burley L. Lyons Jr.Executive
BG
Bryan GrulkeNamed on SEC filing
SF
Shawn FojtikNamed on SEC filing
TW
Terry WallNamed on SEC filing
MP
Michael P. SavageMr. Savage is a Member of the Issuer.
NB
Nicholas BursiMr. Bursi is a Member of the Issuer.
EA
Eric A. RojasMr. Rojas is a Member of the Issuer.
DB
Dudley B. PillowMr. Pillow is a Member of the Issuer.
RD
Roger Dale Criner Jr., MDDr. Criner Jr. is a Member of the Issuer.
Board
JB
Investors · 4
Reported raises · per SEC filings
Form D private placements$4.3M disclosed across 2 rounds · 2015–2020
▶$4MraisedAug 2021 · 18 investors · BiotechnologyRule 506(b)
▶$4MraisedAug 2021 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bryan GrulkeDirector
- Burley L. Lyons JrExecutive Officer, Director
- Jan BoutenDirector
- Shawn FojtikDirector
- M Andrew ForsdickExecutive Officer
- Terry WallDirector
- Offering amount
- $4M
- Amount sold
- $4M
- Minimum investment
- $10K
- Proceeds to insiders
- $580K
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$250KraisedAug 2015 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedAug 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael P. SavageExecutive Officer
- Burley L. Lyons Jr.Executive Officer, Director
- Nicholas BursiExecutive Officer
- Eric A. RojasExecutive Officer
- Dudley B. PillowExecutive Officer
- Roger Dale Criner Jr., MDExecutive Officer
- Tom CharlierExecutive Officer
- Prosperitas LLCExecutive Officer
- John W. Cromwell, MDExecutive Officer
- John SneedExecutive Officer
- University of Tennessee Research FoundationExecutive Officer
- M. Andrew ForsdickExecutive Officer
- Brian KellettExecutive Officer
- Offering amount
- $500K
- Amount sold
- $250K
- Finders' fees
- $10K
- First sale
- Jul 2015
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapLeadIQ6 shared keywordsLeadIQ offers a company search tool that provides B2B company profiles with data such as revenue, employee count, funding, and contact information to help sales teams find decision makers and build pipeline.
AscentX Medical6 shared keywordsAscentX Medical develops injectable regenerative therapy using autologous tissue engineering with microspheres to restore soft tissue function, targeting the aging population and patients in clinical settings. The company is also launching cGMP aseptic fill and finish contract manufacturing (CMO) services for the pharmaceutical and medical device industries.
Adient Medical6 shared keywordsAdient Medical develops absorbable medical devices, including implants designed to remain safe and effective during their useful lifetime and then dissolve on their own, avoiding removal procedures and related complications.
Companies competing with Entac Medical, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Entac Medical, Inc. do?
- Entac Medical develops wearable devices that apply predictive analytics and AI to biological acoustic signals to predict patient adverse events, aiming to improve patient outcomes and reduce hospital readmissions and cost of care. It serves the healthcare sector as a digital health company.
- Who founded Entac Medical, Inc.?
- Entac Medical, Inc. was founded by John W. Cromwell, MD, Buddy Lyons in 2011.
- Who are Entac Medical, Inc.'s investors?
- Entac Medical, Inc.'s investors include Beresford Ventures, Innova Memphis, Inc., iSelect Fund, Innova.
- How much funding has Entac Medical, Inc. raised?
- Entac Medical, Inc. has disclosed $4.3M raised across 2 rounds.
- Where is Entac Medical, Inc. headquartered?
- Entac Medical, Inc. is headquartered in Germantown, US.